Limb girdle muscular dystrophy (LGMD) is a heterogeneous group of genetic disorders that are characterized by progressive muscle weakness with dystrophic muscle pathology. Its clinical diagnosis may include a thorough evaluation by a neuromuscular clinician, serum creatine kinase measurements, genetic testing, and muscle biopsy.1 Despite the several advances in research, there are still challenges that patients and clinicians experience with the disease.
In honor of LGMD Awareness Day, held September 30, 2024, the Muscular Dystrophy Association will host a special live Q&A on the day of the awareness event with their LGMD virtual learning series presenters. Attendees will have the opportunity to ask questions live regarding updates in research and treatment, cardiac care, and exercise/at-home physical therapy for LGMD. The Q&A panelists will include the following experts: Peter Kang, MD; Forum Kamdar, MD, PhD, FACC, FHFSA; Molly Stark, PT, DPT.
The event is at no cost for members of the MDA community or healthcare providers although registration is required. If there are those who are interested in the event but not able to attend, an on-demand recording will be available approximately 3 weeks after the live program but registration online will still be needed to ensure an email with the link is received. To register for the online event hosted by the MDA on September 30, 2024, held at 4pm ET, click the link here.
One of the Q&A panelists, Kamdar, an advanced heart failure physician-scientist at the University of Minnesota, recently discussed how interdisciplinary collaboration helps to improve care for patients with neuromuscular cardiomyopathies in an interview with NeurologyLive®. She also shared innovative techniques in development to study the heart failure mechanisms in muscular dystrophies. Moreover, Kamdar spoke about how she manages the balance between patient care, research, and mentoring in her demanding role.
NeurologyLive: What are some of the main responsibilities you have in your role?
Clinical Facts on LGMD
- LGMD is a term for a group of diseases that cause weakness and wasting of the muscles in the arms and legs.
- There are more than 30 known sub-types of LGMD with more being discovered each year.
- LGMD can affect the heart and muscles necessary for breathing.
REFERENCES
1. LGMD Facts. LGMD Awareness Foundation. Accessed September 26, 2024. https://www.lgmd-info.org/wp-content/uploads/2021/05/List-of-LGMD-Facts.pdf
Forum Kamdar, MD, PhD, FACC, FHFSA: As a heart failure physician-scientist, I have a dual role in patient care and research, with a focus on neuromuscular heart failure. Clinically, I see patients in the interdisciplinary Neuromuscular Cardiomyopathy Clinic, which is a unique clinic dedicated to screening and treating heart involvement patients with living with muscular dystrophies and neuromuscular disorders. Some of my responsibilities include managing complex patient care, coordination of interdisciplinary care with neuromuscular neurologists, pulmonologists, and other specialists.
As an advanced heart failure physician, I also treat heart failure associated with muscular dystrophy with medical therapies and if appropriate consider advanced heart failure therapies including heart transplantation and ventricular assist device implantation. Additionally, I teach and mentor trainees to promote their professional growth and development.I lead a research program in Neuromuscular and Genetic Cardiomyopathies that spans from basic bench research to patient-oriented clinical research. We aim to better understand the mechanisms of heart failure in muscular dystrophies and to develop more effective treatments, ultimately improving patient’s lives.
Could you describe a typical day in your work?
A typical day in my work varies depending on whether I'm in the clinic, on the hospital heart failure service, or focusing on research. I enjoy the diversity in my daily tasks, which keeps my work both engaging and rewarding. In the clinic, I evaluate and treat cardiovascular issues in patients living with neuromuscular diseases, working closely with neuromuscular neurologists and other specialists to coordinate comprehensive care.